BioCentury
ARTICLE | Company News

Management tracks

March 21, 2017 11:10 PM UTC

The Relypsa Inc. gastrointestinal subsidiary of Galencia Ltd. (SIX:GALN) said President and CEO John Orwin will resign. Scott Garland will be promoted to president effective March 31, and Orwin's resignation as CEO will take effect June 30. Garland was SVP and chief commercial officer.

Immunology company IRX Therapeutics Inc. (New York, N.Y.) named Mark Leuchtenberger president and CEO, and Monil Shah COO. Leuchtenberger was president and CEO at Chiasma Inc. (NASDAQ:CHMA). Shah was the medical affairs lead for immuno-oncology at Bristol-Myers Squibb Co. (NYSE:BMY)...